6-K/A

AMENDMENT TO FORM 6-K

Company: Scinai Immunotherapeutics Ltd.
Filed: February 10, 2020
Period of Report: February 10, 2020
Accession Number: 0001213900-20-003126

View Document ↗ View on SEC.gov ↗